Author: Autolus Therapeutics plc

Posted Date:

April 21, 2026

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics plc

April 21, 2026
Autolus Therapeutics to Participate in Upcoming Investor Conferences

Autolus Therapeutics plc

April 7, 2026
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Autolus Therapeutics plc

March 27, 2026
Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026

Autolus Therapeutics plc

March 16, 2026
Autolus Therapeutics to Participate in Upcoming Investor Conferences

Autolus Therapeutics plc

February 24, 2026
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics plc

February 4, 2026